如何向SCI生物医学期刊投稿.ppt

《如何向SCI生物医学期刊投稿.ppt》由会员分享，可在线阅读，更多相关《如何向SCI生物医学期刊投稿.ppt（56页珍藏版）》请在淘文阁 - 分享文档赚钱的网站上搜索。

1、如何向SCI生物医学期刊投稿 Still waters run deep.流静水深流静水深,人静心深人静心深 Where there is life,there is hope。有生命必有希望。有生命必有希望Scientific communication is a two-way process A scientific experiment is not complete until the result have been published，read,and understood(readable)What Journal Editors WantWhat Journal Editor

2、s Want新颖性新颖性重要性重要性真实性真实性可读性可读性重视读者重视读者How to Write a English PaperGetting OrientedFollow the journals guidelines!Medical College of Ohio,Toledo Mulford Libraryhttp:/mulford.meduohio.edu/instr/CONSORT Statement for reporting randomized controlled Trials，http:/www.consort-statement.orgUniform Requirem

3、ents for Manuscripts Submitted to Biomedical Journals，http:/www.icmje.org/Publishing&Editorial Issues Manuscript Preparation Ethical Consideration Guidelines for AuthorsPreparing the ArticleIMRAD FormatIntroduction（前言）（前言）:Why did you start?Methods（方法）（方法）:What did you do?Results（结果）（结果）:What did yo

4、u find?andDiscussion（讨论）（讨论）:What does it mean?1.文题文题(title)Most important part of the paper To attract readers Content of TitlesIndependent variable(s)Dependent variable(s)Who or what was studied Circumstances of data collection Research designEffect of X on Y in/under Z Y in ZHow to Writing Titles

5、Omit the phrasesThe Role ofA Study of/on Preliminary Studies ofObservations on Contributions to A Review ofClinic ExperienceThe，A，AnHow to Writing TitlesSubtitleInfluenza Vaccination in the Elderly:A Randomized,Double-blind,Placebo-Controlled Trial2.作者作者(authors)Authorship:substantive intellectual c

6、ontributionsList authors in orderCorresponding authorAvoid ghost writing3.摘要摘要(abstract)Most important part of a biomedical article,after the titleFor readersFor the reviewersTypes of Abstracts Publication abstracts -Unstructured abstract descriptive informative -Structured abstractUnstructured Abst

7、ract Descriptive abstract -Used for review articles -Usually limited to 150 wordsInformative abstract -Used for research papers -Consists of four section -Usually limited to 150 to 250 words Structured AbstractOften required for original papers To include several short headingsUsually limited to 250

8、 wordsHow to Write AbstractsShould be specific&selectiveAvoid vague statementsNot contain figures,tables,and citations of referencesWrite in phrases under headings of a structured abstractProblems with AbstractsMissing informationInconsistencies with full article4.前言前言(introduction)FUNCTIONS To tell

9、 what the study is aboutTo tell why the study is important5.方法（方法（Methods）FUNCTIONSTo allow readers to judge the quality of the studyTo allow the study to be repeated(maybe)To establish the authors credibilityMethodsMaterial/Subject -Material or drugs -SubjectsMethods -Protocol -Methods of measureme

10、n -Analysis of data -Methods of randomization -Ethical approvalMethodsChronological orderAvoid trade name or proprietary nameHuman subjects:IRB informed consentStatistical analysesFUNCTIONSTo tell what happened during the studyTo present the findings(data)of the studyTo explain any changes from the

11、study as planned6.结果结果(results)ResultsTwo ingredientsUse text,figures,and tablesUnexpected results Explain any missing dataThe exact P value(unless P 0.001)P0.012，P0.86Table 2.Serum cytokines level of the patients with the coronary artery disease (pg/ml)Group n.IL-1 sIL-2R IL-6 TNF-IFN-Control 40 0.

12、20 99.17 5.72 14.62 63.89 AMI 40 20.52*312.52*46.10*88.03*87.62 UAP 40 28.66*327.41*49.95*58.00*78.56 AMI:acute myocardial infarction;UAP:unstable angina pectoris；IL-1:interleukin-1;sIL-2R:soluble interleukin-2 receptor;IL-6:interleukin-6;TNF-:tumor necrosis factor-;IFN-:interferon*P 0.05 compared w

13、ith control group.(*P 0.05 AMI group vs.control group.)7.7.讨论讨论(discussion)FUNCTIONSTo explain the findingsTo tell why they are importantShould discuss the implications of results,not repeat themComparison of results with previous work Discussing limitationsyour conclusion Discussion8.参考文献（参考文献（Refe

14、rences）引用重要的、相关的、已发表的原始文献引用重要的、相关的、已发表的原始文献以近期文献为主，尤应注意以近期文献为主，尤应注意近近3 3年年的文献的文献,综述尤强调综述尤强调“新新”核查文献核查文献，确保每一个细节均准确无误，确保每一个细节均准确无误正文中引用的文献正文中引用的文献必须出现在文后参考文献表中必须出现在文后参考文献表中以文中以文中出现先后排列文献序号出现先后排列文献序号,文献文献15不能出现在不能出现在9前前不用文献自动生成格式标注不用文献自动生成格式标注Creput C,Durrbach A,Samuel D et al.Incidence of renal andLi

15、ver rejection and patient survival rate following combined liver and kidney transplantation.Am J Transplant 2003;3:348-356.R.G.Uzzo and A.C.Novick,Nephron sparing surgery for renal tumors:indications,techniques and outcomes,J Urol 166(2001),p.6.Sondheimer,N.,and Lindquist,S.(2000).Rnq1:an epigenetic

16、 modifier of protein function in yeast.Mol.Cell 5,163-172.ReferencesMaking Your Writing EffectivelyUse the first personVerb tenses in the paper:-Present tense -Past tenseAvoid abbreviationsUSE STOCK PHRASESState the problem:To determine whether,weTo determine the cause ofTo investigateTo evaluate an

17、d validateTo answer this question,weTo test the hypothesis that,weWe asked whetherMaking Your Writing EffectivelyUSE STOCK PHRASESMethods:We measuredWe studiedWe assessedWe comparedMaking Your Writing EffectivelyUSE STOCK PHRASESResults:We found that Answer:We conclude thatThese experiments demonstr

18、ate thatThese findings show thatThese results indicate thatThus,Therefore Making Your Writing EffectivelyMaking Your Writing EffectivelySpell out any number that begins a sentenceFor number of 10 000 or greater,use a half-space to separate every 3 digits How to Publish a English PaperTo read the gui

19、delines of authorsTo scan a recent issue of the journalsHow to Choose a JournalHow to Choose a JournalScopePrestigePublication lagAcceptance rateAudienceOpen policyPayments2010 Cited InformationJ TitleTCIFEigenfactorTM ScoreArticle InfluenceTM ScoreNEJM227 67453.4840.6916721.366Nature511 14536.1011.

20、7446619.334Lancet155 73433.6330.3803112.720Cell167 58732.4010.7047220.639Science469 70431.3641.4648516.859JAMA117 49530.0110.3097312.443Editorial PoliciesDuplicate publication or submissionCopyright transferConflict of interest statementClinical trial registration1.Duplicate SubmissionAcceptable Sec

21、ondary Publication：Certain types of articles,such as guidelinesIn the same or another language,especially in other countries,is justifiable and can be beneficial provided that the following conditions are met 2.CopyrightCopyright transfer agreementCopyright permissionsWorks made for hire3.Conflict o

22、f interestAn author(or the authors institution),reviewer,or editor has financial or personal relationships that inappropriately influence(bias)his or her actions(such relationships are also known as dual commitments,competing interests,or competing loyalties).Statement:disclosing all financial and p

23、ersonal relationships that might bias authors work4.Clinical Trial RegistrationThe ICMJE member journals will require,as acondition of consideration for publication in their journals,registration in a public trials registry.Medical interventionsClinicalTrial AmericaISRCTN EnglangANZCTR Australian,Ne

24、w ZealandUMIN JapanDRKS GermanChiCTR ChineseTRIAL DutchNIPH JapaneseCRIS KoreanIRCT IranianReBEC PortugueseRPCEC SpanishInternational Clinical Trials Registry Platform(ICTRP)Manuscript SubmissionFollow the journals guidelines Manuscript checklist CONSORT checklist&flow diagram(http:/www.consort-stat

25、ement.org)Article titledWhat kind of articleDescribe the research Why it is worth publishingNot been published beforeWriting the Cover LetterCopyright assignment Affirmation of originalityConflict of interest statementPermission to reprint figures or tablesAuthorship FormResponding to Reviewers CommentsRespond to every commentIf you agree with the commentIf you disagree with the comment